NOS3 and diabetes mellitus: In a high-dose STZ model, GFR was remarkably (~65%) decreased in diabetic eNOS −/− mice compared with nondiabetic control [44], while in low-dose STZ models diabetes increased GFR in eNOS −/− mice, although it did not reach the levels in diabetic eNOS +/+ mice [32, 39].